E-poster No. / 壁報編號
C27
Title / 題目
Clinical efficacy of CDK4/6 inhibitor rechallenge after progression on prior CDK4/6 inhibitor treatment in HR+/HER2− metastatic breast cancer (MBC): a systematic review and meta-analysis
First Author / 第一作者
Shuhan Chang
Institution / 單位
Department of Oncology, National Taiwan University Hospital
Audio / 音訊檔
Author Group / 作者群
Yen-Shen Lu, M.D., Ph.D.
Chia-Chen Li, M.D.
Author Group Institution/ 作者群單位
Department of Oncology, National Taiwan University Hospital
Category / 主題分類
Clinical Research
Keyword / 關鍵字
1. HR+/ HER2- MBC, 2. CDK4/6 inhibitor 3. Rechallenge